क्यूआर कोड

Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis.

<h4>Background</h4>Current treatment regimens for pulmonary tuberculosis require at least 6 months of therapy. Immune adjuvant therapy with recombinant interferon-gamma1b (rIFN-gammab) may reduce pulmonary inflammation and reduce the period of infectivity by promoting earlier sputum clearance.<h4>Me...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Rod Dawson, Rany Condos, Doris Tse, Maryann L Huie, Stanley Ress, Chi-Hong Tseng, Clint Brauns, Michael Weiden, Yoshihiko Hoshino, Eric Bateman, William N Rom
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Public Library of Science (PLoS) 2009-09-01
श्रृंखला:PLoS ONE
ऑनलाइन पहुंच:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0006984&type=printable
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन